TRIB1 and metabolic dysfunction-associated steatotic liver disease: In consideration of the tight association of NAFLD with the dysregulation of lipids metabolism and the risk of cardiovascular disease [20–22], it is meaningful to explore the effect of TRIB1 rs17321515 and rs2954029 in the NAFLD patients.